Institute for OneWorld Health awarded Skoll Foundation's Social Entrepreneurship Award


San Francisco, Calif. –March 21, 2005 – The Institute for OneWorld Health today announced that it has been awarded a 2005 Skoll Award for Social Entrepreneurship in the amount of $615,000 over three years. Based in San Francisco, OneWorld Health is the first nonprofit pharmaceutical company in the U.S. and develops new medicines to cure infectious diseases that disproportionately affect the poorest people in the world.

OneWorld Health is one of 13 organizations receiving $7.3 million from the Skoll Foundation through an open competitive process that identifies social entrepreneurs who have piloted innovative programs and are ready to take the next steps toward systemic social change. The awards will be presented on March 31 at the second annual Skoll World Forum on Social Entrepreneurship at Oxford University in England, where some of the world's leading practitioners and thought leaders in social entrepreneurship will convene to set the future agenda for visionaries who want to transform society.

"OneWorld Health is honored to be among this year's Skoll Award recipients," said Dr. Victoria Hale, founder and CEO of the Institute for OneWorld Health. "The Skoll Foundation recognizes the challenges each of our organizations face, and is leading the philanthropic community in its commitment to social innovators."

The Skoll Foundation's mission is to advance systemic change benefiting communities around the world by investing in, connecting and celebrating social entrepreneurs, who are individuals dedicated to creating new solutions that result in lasting improvements to complex social problems.

"We have cast our net far and wide to find the world's best social entrepreneurs," said Sally Osberg, President and CEO of the Skoll Foundation. "OneWorld Health is tackling a complex social problem in order to promote healthy, sustainable communities."

Source: Eurekalert & others

Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
    Published on All rights reserved.